Werling Hans-Otto

New 3-substituted 6-anilino-uracil derivatives, useful as antibacterial agents with high solubility and good activity against Gram positive bacteria

Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]nonyl-quinolonecarboxylic and -naphthyridonecarboxylic acids derivatives for therapy of infections caused by Heliobacter pylori and gastroduodenal diseases associated therewith, novel compounds of this type and medicaments in which those compounds are comprised

Substituted aminothiazoles and the use thereof as active antimicrobial substances

USE OF 7-(2-OXA-5,8-DIAZABICYCLO[4.3.0]NON-8-YL)-QUINOLONECARBOXYLICACID AND -NAPHTHYRIDONECARBOXYLICACID DERIVATIVES FOR THE THERAPY OFHELICOBACTER PYLORI INFECTIONS AND ASSOCIATED GASTRODUODENAL DISORDERS ASSOCIATED THEREWITH

Anvendelse av 7-(2-oksa-5,8-diazabicyklo[4.3.0]non-8-yl)-kinolonkarboksylsyre og naftyridonkarboksylsyrederivater for fremstilling av legemidler for behandling av helicobacter pylori infeksjoner og dermed forbundede gastroduodenale sykdommer, diastereomerrene og enantiomerrene forbindelser, anvendelse derav samt legemiddel inneholdende disse.

Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl quinolone carboxylic acid and -naphthyridone carboxylic acid derivatives for preparing medicaments intended for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases and

8-Cyano-1-cyclopropyl-6-fluoro-7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, its use and medicaments in which the acid is comprised

The use of 8-cyano-1-cyclopropyl-6-fluoro-7-(2-oxa-5,8- diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and its use and medicaments containing this compound

7-(2-oksa-5,8-diasabitsüklo[4.3.0]non-8-üül) kinoloonkarboksüülhappe ja -naftüridoonkarboksüülhappederivaadid kasutamiseks Helicobacter pylori infektsioonide ja nendega kaasnevate gastroduodenaalsetehaiguste raviks

Anvendelse af 7-(2-oxa-5,8-diazabicyclo[4.3.0]quinoloncarboxylsyre- og naphthydridoncarboxylsyrederivater til fremstilling af et lægemiddel til behandling af Helicobacter-pylori-infektioner og dermed associerede gastroduodenale sygdomme